Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
62.70
+1.80 (2.96%)
At close: Feb 26, 2026
21.75% (1Y)
| Market Cap | 6.73B |
| Revenue (ttm) | 9.52B |
| Net Income (ttm) | 537.75M |
| Shares Out | 107.42M |
| EPS (ttm) | 4.99 |
| PE Ratio | 12.58 |
| Forward PE | n/a |
| Dividend | 1.40 (2.23%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 599,360 |
| Average Volume | 886,844 |
| Open | 61.20 |
| Previous Close | 60.90 |
| Day's Range | 61.20 - 62.90 |
| 52-Week Range | 45.50 - 65.80 |
| Beta | -0.08 |
| RSI | 63.29 |
| Earnings Date | Jan 28, 2026 |